Not recruiting yet
Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
NCT05576766 · Peking University First Hospital · Updated 21 Aug 2025
- What is being tested
- Routine care; ERAS management pathway
- For
- Prostate Cancer; Robot-Assisted Laparoscopic Radical Prostatectomy; Enhanced Recovery After Surgery (ERAS) Protocol; Prehabilitation; Length of Hospital Stay
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 60 years to 90 years. About 54 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started Sept 2025, ends Dec 2026. Registered 13 Oct 2022.
- Results
- None posted yet.
In the researchers' words
Prostate cancer ranks second among all malignances in men and has become a significant threat to men's health. Robot-assisted laparoscopic radical prostatectomy (RARP) has become a standard treatment for prostate cancer. How to improve recovery following RARP surgery is worth investigating. The enhanced recovery after surgery (ERAS) pathway involves a series of evidence-based procedures. It is aimed to reduce the systemic stress response to surgery and shorten the length of hospital stay. This randomized trial aims to investigate the impact of Enhanced Recovery After Surgery (ERAS) Pathway on early outcomes after RARP surgery.
Sites
- Department of Anesthesiology and Critical Care Medicine, Peking University First HospitalBeijing, Beijing Municipality, China